HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma.

Abstract
Sirtuin1 (SIRT1) is a nicotinamide adenine dinucleotide-dependent deacetylase. Recently, it is suggested that SIRT1 may be involved in the development of malignant tumors including mouse lymphoma. Therefore, we investigated the prevalence and the prognostic impact of SIRT1 expression in diffuse large B-cell lymphoma (DLBCL). Immunohistochemical expression of SIRT1, p53, bcl2, CD10, bcl6, and multiple myeloma-1 (MUM1) were evaluated by using a 2 mm core from 104 DLBCL patients for tissue microarray. Positive expression of SIRT1 was seen in 74% (77/104) of patients. In total DLBCL patients, SIRT1 and p53 expression were significantly associated with shorter overall survival (OS) by univariate analysis (P=0.001 and P=0.011, respectively). SIRT1 was also an independent prognostic factor by multivariate analysis (P=0.01). According to the expression patterns of CD10, bcl6, and MUM1, germinal center B cell (GCB) types were represented in 38 cases (37%) and non-GCB types were represented in 66 cases (63%). In the GCB type, only p53 expression was associated with a significantly shorter OS (P=0.032). In the non-GCB type, expression of SIRT1 correlated with shorter OS by univariate analyses (P=0.005) and multivariate analyses (P=0.049). In conclusion, we showed that SIRT1 expression is a clinically significant prognostic indicator for DLBCL patients.
AuthorsKyu Yun Jang, Sung Ho Hwang, Keun Sang Kwon, Kyung Ryoul Kim, Ha Na Choi, Na-Ri Lee, Jae-Yong Kwak, Byung-Hyun Park, Ho Sung Park, Myoung Ja Chung, Myoung Jae Kang, Dong Geun Lee, Hun Soo Kim, Hyeok Shim, Woo Sung Moon
JournalThe American journal of surgical pathology (Am J Surg Pathol) Vol. 32 Issue 10 Pg. 1523-31 (Oct 2008) ISSN: 1532-0979 [Electronic] United States
PMID18724249 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Interferon Regulatory Factors
  • Proto-Oncogene Proteins c-bcl-2
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • interferon regulatory factor-4
  • Neprilysin
  • SIRT1 protein, human
  • Sirtuin 1
  • Sirtuins
Topics
  • B-Lymphocytes (pathology)
  • Biomarkers, Tumor (analysis)
  • Disease-Free Survival
  • Female
  • Germinal Center (pathology)
  • Humans
  • Immunohistochemistry
  • Interferon Regulatory Factors (analysis)
  • Kaplan-Meier Estimate
  • Lymphoma, Large B-Cell, Diffuse (enzymology, pathology, therapy)
  • Male
  • Middle Aged
  • Neprilysin (analysis)
  • Proportional Hazards Models
  • Proto-Oncogene Proteins c-bcl-2 (analysis)
  • Sirtuin 1
  • Sirtuins (analysis)
  • Time Factors
  • Tissue Array Analysis
  • Treatment Outcome
  • Tumor Suppressor Protein p53 (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: